CN102010868A - Garrupa MHC (Major Histocompatibility Complex) IIB gene as well as cloning method and application thereof - Google Patents
Garrupa MHC (Major Histocompatibility Complex) IIB gene as well as cloning method and application thereof Download PDFInfo
- Publication number
- CN102010868A CN102010868A CN2010102629467A CN201010262946A CN102010868A CN 102010868 A CN102010868 A CN 102010868A CN 2010102629467 A CN2010102629467 A CN 2010102629467A CN 201010262946 A CN201010262946 A CN 201010262946A CN 102010868 A CN102010868 A CN 102010868A
- Authority
- CN
- China
- Prior art keywords
- mhc
- gene
- iib
- cabrilla
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims abstract description 16
- 238000010367 cloning Methods 0.000 title claims abstract description 9
- 108700018351 Major Histocompatibility Complex Proteins 0.000 title abstract description 11
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 title abstract description 11
- 201000010099 disease Diseases 0.000 claims abstract description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 29
- 208000035240 Disease Resistance Diseases 0.000 claims abstract description 27
- 238000009395 breeding Methods 0.000 claims abstract description 11
- 230000001488 breeding effect Effects 0.000 claims abstract description 11
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 5
- 241000321428 Epinephelus guttatus Species 0.000 claims description 54
- 239000002299 complementary DNA Substances 0.000 claims description 15
- 230000002068 genetic effect Effects 0.000 claims description 14
- 239000003550 marker Substances 0.000 claims description 14
- 241000251468 Actinopterygii Species 0.000 claims description 13
- 238000013461 design Methods 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 238000010839 reverse transcription Methods 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 4
- 238000002474 experimental method Methods 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000012216 screening Methods 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 101150076359 Mhc gene Proteins 0.000 description 14
- 235000019688 fish Nutrition 0.000 description 13
- 241000357444 Epinephelus coioides Species 0.000 description 12
- 238000011160 research Methods 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 7
- OQEBIHBLFRADNM-UHFFFAOYSA-N D-iminoxylitol Natural products OCC1NCC(O)C1O OQEBIHBLFRADNM-UHFFFAOYSA-N 0.000 description 6
- 102100028572 Disabled homolog 2 Human genes 0.000 description 6
- 101000915391 Homo sapiens Disabled homolog 2 Proteins 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 208000035143 Bacterial infection Diseases 0.000 description 5
- 102100028561 Disabled homolog 1 Human genes 0.000 description 5
- 101000915416 Homo sapiens Disabled homolog 1 Proteins 0.000 description 5
- 208000022362 bacterial infectious disease Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 108700024394 Exon Proteins 0.000 description 3
- 241000694873 Paralichthyidae Species 0.000 description 3
- 241001494106 Stenotomus chrysops Species 0.000 description 3
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000277263 Salmo Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000010523 cascade reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 102000054766 genetic haplotypes Human genes 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FQZJYWMRQDKBQN-UHFFFAOYSA-N tricaine methanesulfonate Chemical compound CS([O-])(=O)=O.CCOC(=O)C1=CC=CC([NH3+])=C1 FQZJYWMRQDKBQN-UHFFFAOYSA-N 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100263837 Bovine ephemeral fever virus (strain BB7721) beta gene Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101100316840 Enterobacteria phage P4 Beta gene Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101150062179 II gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241001454698 Teleostei Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940072040 tricaine Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a garrupa MHC (Major Histocompatibility Complex) IIB gene as well as a cloning method and application thereof. The nucleotide sequence of the garrupa MHC IIB gene is shown as SEQ ID NO:1, and the amino acid sequence of protein encoded by the gene is shown as SEQ ID NO:2. In the invention, by using a homologous cloning method, the MHC IIB gene is separated from garrupa, 12 different MHC IIB gene types are identified, the correlation between the polymorphism and the disease resistance of the MHC IIB gene are analyzed, and 6 molecular marks of the MHC IIB gene relevant to the disease resistance of the garrupa are screened; and the cloning method is suitable for screening the marks relevant to the disease resistance of the garrupa and breeding disease-resistant species.
Description
Technical field
The present invention relates to the genetically engineered field, be specifically related to a kind of cabrilla MHC IIB gene and cloning process and application.
Background technology
Major histocompatibility complex (major histocompatibility complex, MHC) be the highly polymorphic gene group of ubiquitous class coding immunoglobulin-like receptor in vertebrates, this gene group has vital role in immunity system, be one of focus of immune in recent years direction research.Mhc gene is divided into I type, II type and III type, and II type gene is divided into IIA and IIB again.MHC II genoid coded product is a MHC II quasi-molecule, and they combine with the exogenous antigen peptide and submission is given t helper cell, cause the immunne response in downstream.Many studies show that, the polymorphism of MHC II gene is closely related with individual resistance against diseases.
MHC II quasi-molecule is a heterodimer, is made up of a α polypeptide chain and a beta polypeptides chain.These two chains all stride the film district by two nuclear outskirts (α 1/ α 2 and β 1/ β 2), land, one and a cytoplasmic domain is formed.α 1/ β 1 forms the polypeptide land, and (Peptide Binding Region PBR), has the height polymorphism, and the little peptide that its effect is with antigen resolves into combines, to give the T cell with its submission; The zone that α 2/ β 2 forms does not have the height polymorphism, is MHC molecule and T cell bonded important structure territory.
MHC II quasi-molecule has the height polymorphism, and especially in its polypeptide land (peptide-bindingregion, PBR), the antigen peptide generation effect that this zone is direct and antigen is cracked into, and then cause the immune cascade reaction in downstream.The allelotrope of MHC II exists the non-synonym of higher proportion to replace (non-synonymous Substitution) usually in the PBR zone.In fact, MHC shows gene of high polymorphism in all knowns, and finding in the mankind's research only just has 500 allelotrope of surpassing on a locus.Mhc gene selects to keep its polymorphism by balance, and mhc gene has linkage disequilibrium (linkage disequilibrium) and two characteristics of haplotype (Haplotype) heredity in heredity.
The height polymorphism of MHC molecule has profound significance, and it gives the ability that population adapts to changeable envrionment conditions, realizes the Genetic Control to immune response, and makes MHC become individual lifelong genetic marker.The polymorphism of MHC is also closely bound up with individual resistance against diseases, has all delivered the article of MHC polymorphism and body disease-resistant power correlation research in chicken, mammals, fish.The MHC polymorphism all is an extremely important material at aspects such as the research of the research of phyletic evolution, population protection and genetic breedings, is a focus of current mhc gene research.
The α of fish MHC II and β gene generally are linkage inheritances.At present in surpassing 30 kinds of teleostei the clone obtain mhc gene and proved its polymorphism, as zebra fish, carp, Atlantic salmon, lefteye flounder, Tiao Wen Shi Sushi, porgy etc.
Fish mhc gene function is identical with mammals, participates in antigen presentation and causes immune cascade reaction.Studies show that the gene fragment (being generally second exon on the mhc gene) of coding PBR structural domain also has the height polymorphism in the fish mhc gene, and closely related with the immune disease-resistance ability of fish.
Screen disease-resistance population Deng with the Atlantic salmon of 7 about 2000 tails of family with 5 kinds of MHC I allelotrope and 4 kinds of MHC II allelotrope combinations and in conjunction with traditional family selective breeding mode at ISA (infections anaemia), successfully filter out effective disease-resistant gene type combination, this has started and has used MHC to carry out the beginning of the disease-resistant assistant breeding of fish.After this, in lefteye flounder, carp, also there is similar research to be in the news.At present, still not having any research about the cabrilla mhc gene both at home and abroad is in the news.
Summary of the invention
The objective of the invention is to according in the prior art to the still incomplete problem of the research of mhc gene, a kind of and the disease-resistant relevant cabrilla MHC IIB gene of cabrilla are provided.
Another purpose of the present invention is to provide the allelotrope on the above-mentioned cabrilla MHC IIB gene.
Another purpose of the present invention is to provide the albumen of above-mentioned cabrilla MHC IIB genes encoding.
Another purpose of the present invention is to provide the cloning process of above-mentioned cabrilla MHC IIB gene.
Another purpose of the present invention is to provide the detection method of the sequence polymorphism of above-mentioned cabrilla MHC IIB gene.
A further object of the invention is to provide the application of above-mentioned cabrilla MHC IIB gene.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
A kind of cabrilla MHC IIB gene, its sequence are shown in SEQ ID NO:1, and this gene is to separate from the Epinephelus coioide spleen by the method for homologous clone to obtain.At least have 12 different allelotrope in the described gene, its nucleotide sequence is shown in SEQ ID NO:3~14.
The albumen of above-mentioned cabrilla MHC IIB coded by said gene, shown in its aminoacid sequence SEQ ID NO:2, totally 249 amino acid, iso-electric point is 6.53, molecular weight is 28.31 kilodaltons, cabrilla MHC IIB albumen mainly is divided into 4 structural domains, be respectively Exon1 encoded signals peptide (SP), Exon2 encoded polypeptides land (be β 1 structural domain, PBR), IGc1 district (being β 2 structural domains) and the Exon4 and the part Exon5 of Exon3 coding encode stride the film district.74.0%, 79.1%, 58.4% the albumen of cabrilla MHC IIB coded by said gene and turbot, porgy, rainbow trout, zebra fish, mouse and the proteic homology of people MHC IIB coded by said gene are respectively:.55.2%, 32.0% and 31.5%.
The cloning process of cabrilla MHC IIB gene of the present invention comprises the steps:
(1) extract the total RNA of cabrilla, reverse transcription obtains cDNA article one chain, preparation RACE PCR reaction template;
(2), obtain the cDNA fragment of cabrilla MHC IIB gene according to the homology design degenerated primer of the aminoacid sequence of different plant species MHC IIB; The sequence of described degenerated primer is shown in SEQ ID NO:15~16;
(3) carry out RACE PCR, described primer sequence such as SEQ ID according to gained fragment design primer
Shown in NO:17~22, obtain the MHC IIB full-length cDNA of 1338bp;
(4) according to designing primer with the known MHC IIB exon of the close fish of cabrilla sibship and the boundary site of intron, carry out the intron amplification, obtain the complete genome sequence of cabrilla MHC IIB, described primer is shown in SEQ ID NO:23~30.
Cabrilla MHCIIB Study on gene polymorphism of the present invention, according to synthetic specificity upstream primer EpcoMHC2bPl-F on first exon of cabrilla MHC IIB gene, sequence is shown in SEQ ID NO:31, at the end and the synthetic specificity downstream primer EpcoMHC2bPl-R of the second intron front end of second exon, sequence is shown in SEQ ID NO:32; In 45 different cabrilla individualities, carry out pcr amplification, 145 positive colonies of picking and send order-checking after, obtain the raw data of MHC IIB gene PBR zone polymorphism.Sequencing result shows that there are two different loci in MHC IIB gene in cabrilla, and its molecular weight difference in size is the length difference of Intron 1.The Intron1 size in one of them site is 138bp, called after DAB2; The Intron1 size in another site is widely different at different fingerlings, but always greater than 138bp, called after DAB 1.Co-exist in 12 different sequences in 145 positive colonies of 45 fishes, this shows in cabrilla MHC IIB gene and has 12 different allelotrope at least that its nucleotide sequence is shown in SEQ ID NO:3~14.Wherein 10 allelotrope belong to the DAB1 site, and 2 allelotrope belong to the DAB2 site.With 10 allelotrope called after EpcoDAB*1-01 that belong to the DAB1 site to EpcoDAB*1-10, with 2 allelotrope called after EpcoDAB*2-01 and EpcoDAB*2-02 that belong to the DAB2 site.
The screening of the disease-resistant mark of correlation of above-mentioned cabrilla MHC IIB adopts natural selection and artificial challenge's approach to obtain disease-resistance population and disease-resistance population not.In the morbidity busy season, collect the individuality of morbidity back survival from plant, the fry of collecting with pathogenic bacterial infection simultaneously obtains disease-resistance population and disease-resistance population not according to the opposing survival ability size to pathogenic bacterial infection.321 positive colonies to 81 individualities check order altogether, the result shows, there are 6 kinds of mhc gene type high frequencies to appear in the disease-resistant individuality, EpcoDAB*1-01 wherein, EpcoDAB*1-02, EpcoDAB*1-04, EpcoDAB*1-05, EpcoDAB*2-01 and EpcoDAB*2-02, the frequency that is occurred is respectively 14.81%, 7.41%, 7.41%, 14.81%, 7.41%, 11.11% and 37.04%.
The method of the disease-resistant mark of correlation assistant breeding of above-mentioned cabrilla MHC IIB: the MHC IIB genotype that will occur at the disease-resistance population high frequency is as disease resistance related MHC IIB genetic marker, the parent population of carrying these disease-resistant gene marks is bred, cultivate the offspring, separate the MHC IIB gene among the offspring, research MHC IIB gene pleiomorphism, carry out the cause pathogeny imcrobe infection experiment simultaneously, study disease-resistant MHC IIB genetic marker genetic development and with the relation of fish body disease resistance, therefrom filter out and both contained disease-resistant MHC IIB genetic marker, the fry that disease resistance improves again carries out can setting up disease-resistant varieties after many generation breedings and the cultivation.
Compared with prior art, the present invention has following beneficial effect:
The present invention adopts functional genome's technology, in cabrilla, screen disease-resistant relevant mhc gene mark, tentatively set up the disease-resistant mhc gene marker-assisted breeding of cabrilla technology, this technological operation is simple, seed selection efficient height, suit on all marine fishs, to apply, the cabrilla disease-resistant variety is cultivated significant and using value.
Description of drawings
Fig. 1 is the distribution frequencies of 12 kinds of different genotype of cabrilla MHC IIB in disease-resistance population.
Embodiment
Further explain the present invention below in conjunction with embodiment, but embodiment does not do any type of qualification to the present invention.
Embodiment 1
1. the extraction of the total RNA of cabrilla spleen
Get healthy Epinephelus coioide (Epinephelus coioides), in 2 ages, the about 750g of body weight with the about 1min of MS-222 (tricaine methanesulphonate) anesthesia, isolates spleen immediately after the tail vein is got blood.Adopt Trizol reagent method to extract and obtain the total RNA of cabrilla spleen, its OD260/280=1.85, electrophoresis result shows, 28S rRNA, 18S rRNA band is clear, and the brightness of 28S band is the twice of 18S, show that the total RNA of gained is not polluted the purity height by protein, phenol and genomic dna.
2.cDNA first chain is synthetic
Get the total RNA sample of 5 μ g Epinephelus coioide spleens and carry out the DNA enzyme and handle, mix, carry out reverse transcription with RNA Oligo dT (sequence is shown in SEQ ID NO:33) to remove the pollution of genomic dna, product place-20 ℃ of preservations standby.
3. design of primers
From the GenBank database, download and obtain nearly source species, as hyoid tooth perch (DQ821113), lefteye flounder (AY848955) and porgy MHC II B homologous gene CDS sequences such as (AY190711), utilize ClustalX software to carry out the multisequencing comparison, determine conserved regions, according to definite conserved regions design degenerated primer, the amplified fragments size is about 300bp.
Primer sequence is shown in SEQ ID NO:15~16.
4. the clone of Epinephelus coioide MHC IIB gene cDNA complete sequence
As template, carry out pcr amplification with degenerated primer with the embodiment 2 synthetic first chain cDNA, sample is to the 1.8wt% sepharose on the gained PCR product, and with low voltage electrophoretic separation dna fragmentation, purifying reclaims the purpose product from gel.Purpose product behind the purifying is connected to
The Easy carrier transforms DH5 α intestinal bacteria, selects the positive colony order-checking.Blast homology analysis revealed, purpose product are the intermediate segment of MHC IIB gene.
According to the cDNA fragment sequence that obtained design Auele Specific Primer, utilize the terminal rapid amplifying technology of cDNA (Rapid Amplification ofcDNA ends, RACE) to 3 of goal gene '-and 5 '-end carries out pcr amplification.
Total RNA carries out dephosphorization acid according to RACE test kit GeneRacerTM Kit specification sheets epinephelus coioides spleen, removes mRNA 5 ' cap sequence, is connected with RNA Oligo, finally by synthetic cDNA first chain of reverse transcription.With 3 of Epinephelus coioide MHC IIB cDNA '-and 5 '-RACE special primer (MHC-F2, MHC-F3 and MHC-R2, MHC-R3) and the universal primer of GeneRacerTM Kit, the first chain cDNA is a first round pcr template with GeneRacerTM Kit reverse transcription synthetic, first round PCR product with dilution is second to take turns pcr template, amplification MHC IIB cDNA 3 ' end and 5 ' end fragment are identified and dna sequencing recovery purifying, connection T carrier, transformed into escherichia coli, the positive colony of resulting PCR product.Order-checking institute calling sequence utilizes Clustal X software to splice with the sequence of degenerated primer amplification gained again.
The special primer sequence is shown in SEQ ID NO:17~22.
5. the acquisition of Epinephelus coioide MHC IIB genomic dna complete sequence
From the cabrilla liver, extract its total DNA, use the marine animal genome to extract test kit, extract genomic dna with the method for chromatography column.Carry out the amplification of intron according to the known MHC IIB gene extron of the close fish of other sibships and the dividing point design Auele Specific Primer (sequence such as SEQ ID NO:23~30) of intron.Similar with other vertebrate MHC IIB genome structure, cabrilla MHC IIB genome includes 5 exons and 4 introns, wherein the length of 5 exons is respectively 74bp, 273bp, 282bp, 114bp and 595bp, and introne 1,2,3 and 4 length is respectively 192bp, 273bp, 118bp and 108bp; Measure the sequence of whole 5 exons and 4 introns, obtained cabrilla MHC IIB complete genome sequence.
Embodiment 2 Epinephelus coioide MHC IIB nucleotide sequence variations
According to synthetic specificity upstream primer EpcoMHC2bPl-F on first exon of cabrilla MHC IIB gene, sequence is shown in SEQ ID NO:31, at the end and the synthetic specificity downstream primer EpcoMHC2bPl-R of the second intron front end of second exon, sequence is shown in SEQ ID NO:32; In 45 different cabrilla individualities, carry out pcr amplification, 145 positive colonies of picking and send order-checking after, obtain the raw data of MHC IIB gene PBR zone polymorphism.Sequencing result shows that there are two different loci in MHC IIB gene in cabrilla, and its molecular weight difference in size is the length difference of Intron 1.The Intron1 size in one of them site is 138bp, called after DAB2; The Intron1 size in another site is widely different at different fingerlings, but always greater than 138bp, called after DAB1.Co-exist in 12 different sequences in 145 positive colonies of 45 fishes, this shows in cabrilla MHC IIB gene and has 12 different allelotrope at least.Wherein 10 allelotrope belong to the DAB1 site, and 2 allelotrope belong to the DAB2 site.With 10 allelotrope called after EpcoDAB*1-01 that belong to the DAB1 site to EpcoDAB*1-10, with 2 allelotrope called after EpcoDAB*2-01 and EpcoDAB*2-02 that belong to the DAB2 site.
The screening of the disease-resistant mark of correlation of embodiment 3 Epinephelus coioide MHC IIB genes
Adopt natural selection and artificial challenge's approach to obtain disease-resistance population and disease-resistance population not.In the morbidity busy season, collect the individuality of morbidity back survival from plant, the fry of collecting with pathogenic bacterial infection simultaneously obtains disease-resistance population and disease-resistance population not according to the opposing survival ability size to pathogenic bacterial infection.321 positive colonies to 81 individualities check order altogether, the result shows, there are 6 kinds of mhc gene type high frequencies to appear in the disease-resistant individuality, EpcoDAB*1-01 wherein, EpcoDAB*1-02, EpcoDAB*1-04, EpcoDAB*1-05, EpcoDAB*2-01 and EpcoDAB*2-02, the frequency that is occurred is respectively 14.81%, 7.41%, 7.41%, 14.81%, 7.41%, 11.11% and 37.04% (Fig. 1).
The disease-resistant mark of correlation auxiliary breeding means of embodiment 4 Epinephelus coioide MHC IIB genes
The MHC IIB genotype that will occur at the disease-resistance population high frequency is as disease resistance related MHC IIB genetic marker, the parent population of carrying these disease-resistant gene marks is bred, cultivate the offspring, separate the MHCIIB gene among the offspring, research MHC IIB gene pleiomorphism, carry out the cause pathogeny imcrobe infection experiment simultaneously, study disease-resistant MHC IIB genetic marker genetic development and with the relation of fish body disease resistance, therefrom filter out and both contained disease-resistant MHC IIB genetic marker, the fry that disease resistance improves again carries out can setting up disease-resistant varieties after many generation breedings and the cultivation.
The MHC IIB genotype that will occur at the disease-resistance population high frequency is as disease resistance related MHC IIB genetic marker, by parent population MHC IIB genotype is screened, pick out and contain EpcoDAB*2-01 and the genotypic male and female Epinephelus coioide of EpcoDAB*2-02 parent population breeds, cultivate the offspring.Separate the MHC IIB gene among the offspring, study their MHC IIB gene pleiomorphism, carry out the cause pathogeny imcrobe infection experiment simultaneously, the fry of collecting detects the opposing survival ability to pathogenic bacterial infection.The result shows and contains EpcoDAB*2-01 and the genotypic fry of EpcoDAB*2-02, the survival ability ratio has common fry to increase by 27%, therefore EpcoDAB*2-01 and EpcoDAB*2-02 can be used as disease-resistant MHC IIB genetic marker, the fry that the production disease resistance is high carries out can setting up disease-resistant varieties after many generation breedings and the cultivation.
Claims (7)
1. cabrilla MHC IIB gene, its nucleotide sequence is shown in SEQ ID NO:1.
2. according to the described cabrilla MHC of claim 1 IIB gene, it is characterized in that existing at least in the described gene 12 different allelotrope, its nucleotide sequence is shown in SEQ ID NO:3~14.
3. the albumen of the described cabrilla MHC of claim 1 IIB genes encoding is characterized in that described proteic iso-electric point is 6.53, and molecular weight is 28.31 kilodaltons, and its aminoacid sequence is shown in SEQ ID NO:2.
4. the cloning process of the described cabrilla MHC of claim 1 IIB gene is characterized in that described method comprises the steps:
(1) extract the total RNA of cabrilla, reverse transcription obtains cDNA article one chain, preparation RACE PCR reaction template;
(2), obtain the cDNA fragment of cabrilla MHC IIB gene according to the homology design degenerated primer of the aminoacid sequence of different plant species MHC IIB; The sequence of described degenerated primer is shown in SEQ ID NO:15~16;
(3) carry out RACE PCR according to gained fragment design primer, described primer sequence obtains the MHC IIB full-length cDNA of 1338bp shown in SEQ IDNO:17~22;
(4) according to designing primer with the known MHC IIB exon of the close fish of cabrilla sibship and the boundary site of intron, carry out the intron amplification, obtain the complete genome sequence of cabrilla MHC IIB, described primer is shown in SEQ ID NO:23~30.
5. the detection method of the described cabrilla MHC of claim 1 IIB nucleotide sequence variation, it is characterized in that described method comprises the steps: according to synthetic specificity upstream primer on first exon of cabrilla MHC IIB gene, sequence is shown in SEQ ID NO:31, at the end and the synthetic specificity downstream primer of the second intron front end of second exon, sequence is shown in SEQ ID NO:32; Carry out pcr amplification in different cabrilla individualities, the picking positive colony checks order, and obtains the data of MHC IIB gene PBR zone polymorphism.
6. the application of the described cabrilla MHC of claim 1 IIB gene is characterized in that described cabrilla MHC IIB gene is used for marker-assisted breeding.
7. according to the application of the described cabrilla MHC of claim 6 IIB gene, it is characterized in that the method that described cabrilla MHC IIB gene is used for marker-assisted breeding is as follows: the MHCIIB genotype that will occur at disease-resistance population is as disease resistance related MHC IIB genetic marker, the parent population of carrying these disease-resistant gene marks is bred, cultivate the offspring, separate the MHCIIB gene among the offspring, carry out the cause pathogeny imcrobe infection experiment, therefrom filter out and both contained disease-resistant MHC IIB genetic marker, the fry that disease resistance improves again carries out can setting up disease-resistant varieties after many generation breedings and the cultivation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102629467A CN102010868A (en) | 2010-08-24 | 2010-08-24 | Garrupa MHC (Major Histocompatibility Complex) IIB gene as well as cloning method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102629467A CN102010868A (en) | 2010-08-24 | 2010-08-24 | Garrupa MHC (Major Histocompatibility Complex) IIB gene as well as cloning method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102010868A true CN102010868A (en) | 2011-04-13 |
Family
ID=43841198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102629467A Pending CN102010868A (en) | 2010-08-24 | 2010-08-24 | Garrupa MHC (Major Histocompatibility Complex) IIB gene as well as cloning method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102010868A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105296500A (en) * | 2015-11-11 | 2016-02-03 | 中山大学 | Epinephelus lanceolatus Neuropeptide B gene and protein and application of gene |
CN112813171A (en) * | 2020-12-17 | 2021-05-18 | 水利部中国科学院水工程生态研究所 | MHC gene primer for cupreous rotundifolia fish and application thereof |
CN114078568A (en) * | 2020-09-14 | 2022-02-22 | 青岛欧易生物科技有限公司 | Metagenome sequencing data processing system and processing method based on IIB type restriction endonuclease characteristics |
-
2010
- 2010-08-24 CN CN2010102629467A patent/CN102010868A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105296500A (en) * | 2015-11-11 | 2016-02-03 | 中山大学 | Epinephelus lanceolatus Neuropeptide B gene and protein and application of gene |
CN105296500B (en) * | 2015-11-11 | 2018-12-25 | 中山大学 | Epinephelus lanceolatus fish Neuropeptide B gene, albumen and its application |
CN114078568A (en) * | 2020-09-14 | 2022-02-22 | 青岛欧易生物科技有限公司 | Metagenome sequencing data processing system and processing method based on IIB type restriction endonuclease characteristics |
CN112813171A (en) * | 2020-12-17 | 2021-05-18 | 水利部中国科学院水工程生态研究所 | MHC gene primer for cupreous rotundifolia fish and application thereof |
CN112813171B (en) * | 2020-12-17 | 2023-05-26 | 水利部中国科学院水工程生态研究所 | MHC gene primer for round-mouth copper fish and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110004235B (en) | SNP locus related to rapid growth of fugu obscurus and application | |
CN109628613B (en) | Molecular marker related to egg laying and egg quality traits of laying ducks and application thereof | |
Liu | Development of genomic resources in support of sequencing, assembly, and annotation of the catfish genome | |
CN112852976A (en) | Molecular marker related to later-stage egg laying traits in laying hen NCS1 gene and application thereof | |
CN112048014B (en) | Penaeus monodon PmGLUT2 gene and application thereof | |
CN105441560A (en) | Chicken body size trait breeding molecular marker IGF-1R (insulin-like growth factor-1 receptor) gene and application thereof | |
Juhua et al. | Isolation of IGF2 and association of IGF2 polymorphism with growth trait in genetically improved farmed tilapias, Oreochromis niloticus L. | |
CN102010868A (en) | Garrupa MHC (Major Histocompatibility Complex) IIB gene as well as cloning method and application thereof | |
CN105624318B (en) | One kind SNP site relevant to lefteye flounder growth traits, its screening technique and application | |
CN100384997C (en) | Lefteye flounder disease resistance related MHC gene marker and subsidiary breeding method | |
CN107937395B (en) | Microsatellite molecular marker for polymorphism of high-sea swimming crabs, and identification method and application thereof | |
Kocher et al. | Genome mapping and genomics in fishes and aquatic animals | |
CN111996261A (en) | Macrobrachium rosenbergii sex molecular marker primer and application thereof | |
EP2038421A2 (en) | A molecular tool to enhance salt tolerance in an organism | |
Latifah et al. | Genetic analysis using partial sequencing of melanocortin 4 receptor (MC4R) gene in Bligon goat | |
CN105296499A (en) | Cyrinus carpio IGF3 gene as well as amplification primer group and amplification method thereof | |
CN112813171B (en) | MHC gene primer for round-mouth copper fish and application thereof | |
CN113604587B (en) | Molecular marker T5198 for rapidly identifying low-temperature tolerant variety of penaeus japonicus and application thereof | |
UKENYE et al. | Comparison of genetic diversity of farmed Oreochromis niloticus and wild unidentified tilapia (Wesafu) using microsatellite markers | |
CN111394473B (en) | Molecular marker related to chicken antler crowns and typing method and application thereof | |
CN106148541B (en) | SNP primer and screening technique for the screening of Fugu rubripes seed | |
Mohammed-Geba et al. | DNA barcoding identifies a unique haplotype of nile tilapia Oreochromis niloticus thriving in Egyptian freshwater and brackish water lakes | |
KR101437383B1 (en) | Method for origin verification of snow crab | |
CN103509099B (en) | Female cynoglossus semilaevis specific expression gene CSW2 and applications thereof | |
CN106148540B (en) | Screen the SNP primer and screening technique of Fugu rubripes seed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110413 |